
Drug Target Review is a leading resource for researchers and scientific leaders in drug discovery and early-phase therapeutic development. They provide up-to-date information on the latest research, developments, and technological advancements in the pharmaceutical and life sciences industries. Their content covers innovations in assays, biomarkers, automation, and AI through various formats including market reports, website articles, digital events, webinars, podcasts, and videos. The platform facilitates connections between industry leaders and technical decision-makers, covering key topics such as stem cells, targets, personalized medicine, and screening. An advisory board of respected global leaders curates the content to ensure high quality.

Drug Target Review is a leading resource for researchers and scientific leaders in drug discovery and early-phase therapeutic development. They provide up-to-date information on the latest research, developments, and technological advancements in the pharmaceutical and life sciences industries. Their content covers innovations in assays, biomarkers, automation, and AI through various formats including market reports, website articles, digital events, webinars, podcasts, and videos. The platform facilitates connections between industry leaders and technical decision-makers, covering key topics such as stem cells, targets, personalized medicine, and screening. An advisory board of respected global leaders curates the content to ensure high quality.